LIBD logo (PRNewsFoto/Lieber Institute for Brain Devel)
What You Should Know:
– The Lieber Institute for Brain Development (LIBD) is expanding its technology capabilities on Amazon Web Services (AWS), migrating its IT infrastructure to fully utilize…
Continue Reading
What You Should Know:
– Nicoya Lifesciences, Inc., a leading provider of advanced biologics characterization tools for drug discovery and development, today announced its acquisition of Applied Photophysics, a UK-based provider of biophysical characterization instrumentation.
– Applied Photophysics, bringing…
Continue Reading
What You Should Know:
– John Snow Labs, the AI for healthcare company announced its acquisition of WiseCube, a pioneer in biomedical knowledge graphs and AI-powered literature analysis. Financial details of the acquisition were not…
Continue Reading
Raj Indupuri, CEO and Co-Founder of eClinical Solutions
For years, the life sciences industry has been trying to address the same R&D challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive,…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guests today are Dr. Nisim Peretz, Co-Founder and CEO, and Dr. Nir Waiskopf, CTO, at…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest is Matti Gill — CEO at AION Labs. Today, we’re diving into the cutting…
Continue Reading
Source: Icahn School of Medicine at Mount Sinai
What You Should Know:
– The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a pioneering initiative that leverages…
Continue Reading
Google gave an update on how it is using AI to advance science and build products at its recent Check Up event.In a blog post, Google’s chief health officer, Dr. Karen DeSalvo, said that…
Continue Reading
At NVIDIA’s GTC 2025 event in San Jose, California, this week – the so-called “Super Bowl of AI” – the chip giant announced multiple partnerships leveraging the power of AI to turbocharge applications in…
Continue Reading
Tech-enabled drug discovery company Insilico Medicine secured $110 million in an oversubscribed Series E funding round. A large equity fund of Value Partners Group, an asset management firm in Asia, and new and existing investors…
Continue Reading
